TDAC Translational executives outline targeted biotech acquisition plans in latest quarterly earnings update MGRE Affiliated posts Q4 2025 EPS ahead of consensus estimates shares edge slightly lower in todays trading session XWIN XMAX posts strong 726 percent year over year Q4 2025 revenue growth shares rise 014 percent IQV IQVIA Holdings records 59 Q4 2025 yearoveryear revenue growth ticks higher despite a narrow consensus EPS miss SOLS Solstice shares edge higher on mild revenue growth despite steep Q4 2025 EPS miss that fell well below analyst forecasts RRBI Red River beats Q1 earnings estimates by 59 but shares decline 071 on sector concerns CVS Health CVS Outperforms Peer Group in Mixed Q4 2025 Health Insurance Earnings Season Stratasys SSYS Stock Backspread Slight Uptick 20260420